Scientific Director, Breast Cancer Portfolio in New York at Jobgether

This position is listed on behalf of a partner company, who manages all applications and next steps. Our partner is looking for a Scientific Director, Breast Cancer Portfolio based in United States.

This is a strategic scientific leadership role focused on advancing evidence generation across a portfolio of breast cancer diagnostic products.
You will shape evidence strategies spanning early development, clinical validation, regulatory submissions, commercialization, and post-market activities.
The role combines deep breast cancer expertise with clinical development, translational research, and diagnostic innovation.
You will lead high-impact studies and scientific collaborations with investigators, academic centers, and research networks.
Working cross-functionally with Product, Medical, Biostatistics, AI, and Market Access teams, you will help turn scientific insights into clinically meaningful outcomes.
Your work will contribute to publications, product claims, reimbursement strategies, guideline adoption, and broader clinical use.
This is an opportunity to make a measurable impact on patient care within a fast-moving, collaborative AI-driven healthcare environment.

• Lead the scientific strategy for the breast cancer evidence portfolio, maintaining an integrated roadmap across products, studies, collaborators, and long-term development objectives.
• Define evidence requirements supporting product development, regulatory submissions, reimbursement, clinical adoption, and potential guideline inclusion.
• Identify evidence gaps, research priorities, opportunities for indication expansion, and next-generation product development.
• Provide scientific oversight for retrospective, prospective, observational, and translational studies, including study concepts, protocols, endpoints, execution, interpretation, and reporting.
• Partner with internal and external stakeholders to identify and prioritize clinical datasets that support evidence-generation objectives.
• Establish and manage relationships with key opinion leaders, academic medical centers, cooperative groups, and research networks.
• Evaluate and develop investigator-initiated and company-sponsored research proposals, assessing scientific merit, feasibility, strategic alignment, and potential clinical impact.
• Develop publication strategies and lead the preparation of abstracts, conference presentations, posters, manuscripts, and other scientific communications.
• Present scientific findings internally and externally, translating complex research into rigorous, clinically relevant insights.
• Collaborate closely with Product, Medical, Biostatistics, AI, and Market Access teams as the clinical development representative on cross-functional initiatives.
• Contribute scientific expertise to product development, target product profiles, product claims, and commercialization strategies.
• Monitor research progress, proactively resolve scientific or operational challenges, and ensure studies remain aligned with portfolio objectives.
• Support evidence generation that advances product development, regulatory and reimbursement objectives, and clinical adoption.

• Advanced degree such as a Ph.D., M.D., Pharm.D., or equivalent in oncology, cancer biology, pathology, molecular biology, epidemiology, or a related scientific discipline.
• At least 5 years of experience in oncology clinical development, translational research, diagnostics, biotechnology, pharmaceutical development, or a closely related field.
• Deep expertise in breast cancer biology and the contemporary breast cancer treatment landscape.
• Demonstrated experience developing and executing clinical studies involving molecular diagnostics, digital pathology, genomic assays, AI-based diagnostics, companion diagnostics, or related technologies.
• Strong understanding of clinical study methodology, observational research, translational research, and evidence generation.
• Proven ability to lead collaborations with academic investigators, cooperative groups, and research networks.
• Track record of peer-reviewed publications as a first author, senior author, or contributing collaborator.
• Experience authoring or reviewing study protocols, research proposals, abstracts, manuscripts, and scientific presentations.
• Experience working across multidisciplinary teams involving scientific, clinical, regulatory, product, and commercial stakeholders.
• Strong strategic thinking, analytical capabilities, project execution skills, and scientific judgment.
• Excellent written, verbal, presentation, and relationship-building skills, with the ability to communicate effectively with clinical and scientific experts.
• Demonstrated ability to influence stakeholders without direct authority and build productive external partnerships.
• Comfortable working independently in a fast-paced startup environment with significant ownership and evolving priorities.
• Passion for improving patient care through AI-enabled healthcare and diagnostic innovation.
• Preferred experience with commercially available diagnostic assays, regulatory submissions, prognostic or predictive breast cancer assays, real-world evidence, outcomes research, digital pathology, AI/ML, or multimodal biomarkers.
• Existing relationships with breast cancer investigators, cooperative groups, or academic research networks are advantageous.
• Willingness to travel domestically and internationally up to approximately 5% for scientific collaboration meetings.

• Base salary: $145,000–$165,000 per year, with final compensation based on experience, qualifications, and other relevant factors.
• Equity as a core component of the overall compensation package.
• 401(k) matching.
• Unlimited paid time off (PTO).
• Remote work environment.
• Opportunity to contribute to innovative AI-driven healthcare and diagnostic technologies.
• Collaborative, cross-functional environment with significant scientific ownership and impact.